Frequency of C825T G protein β3 subunit gene polymorphism and its association with obesity in the Kyrgyz population

Family Medicine and Community Health

Volumn 1, Issue 1, 2013, Pages 23-29

  Erkin, Mirrakhimov ^a   Olga, Lunegova ^b   Aibek, Mirrakhimov ^a   Alina, Kerimkulova ^a   Nurdin, Starov ^a   Yuliya, Zalesskaya ^b   Saamai, Abilova ^a   Malik, Nabiev ^a   Nazira, Alibaeva ^a   Almaz, Aldashev ^c  

^a Kyrgyz State Medical Academy   (Kyrgyzstan)

^b National Center of Cardiology and Internal Medicine   (Kyrgyzstan)

^c Institute of Molecular Biology and Medicine   (Kyrgyzstan)

Author keywords

G protein 3 subunit C825T polymorphism; Hypertension; Obesity

Indexed keywords

EID: 84963499157     PISSN: 23056983     EISSN: 20098774     Source Type: Journal    
DOI: 10.15212/FMCH.2013.0104     Document Type: Article

References (37)

1. Salazar MR, Carbajal HA, Espeche WG, Dulbecco CA, Aizpurua M, Marillet AG. Relationships among insulin resistance, obesity, diagnosis of the metabolic syndrome and cardio-metabolic risk. Diab Vasc Dis Res 2011;8(2):109-16.
2. Comuzzie A., Allison D. The search for human obesity genes. Science 1988;280:1374-7.
3. Gautman N, Downes GB, Yan K, Kiselev O. The G protein betagamma complex. Cell Signal 1998;7:447-55
4. Hildebrandt JD. Role of subunit diversity in signaling by heterotrimetric G proteins. Biochem Pharmacol 1997;54:325-39.
5. Farfel Z, Bourne HR, Iiri T. The expanding spectrum of G protein diseases. N Engl J Med 1999;340:1012-20.
6. Rosskopf D, Busch S, Manthey I, Siffert W. G protein beta 3 gene: structure, promoter, and additional polymorphisms. Hypertension 2000;36:33-41.
7. Hengstenberg C, Schunkert H, Mayer B, Döring A, Löwel H, Hense HW. Association between a polymorphism in the G protein beta3 subunit gene (GNB3) with arterial hypertension but not with myocardial infarction. Cardiovasc Res 2001;49:820-7.
8. Bagos PG, Elefsinioti AL, Nikolopoulos GK, Hamodrakas SJ. The GNB3 C825T polymorphism and essential hypertension: a meta-analysis of 34 studies including 14094 cases and 17760 controls. J Hypertens 2007;25:487-500.
9. Rosskopf D, Manthey I, Siffert W. Identification and ethnic distribution of major haplotypes in the gene GNB3 encoding the G protein beta3 subunit. Pharmacogenetics 2002;12:209-20.
10. Siffert W, Forster P, Jöckel KH, Mvere DA, Brinkmann B, Naber C. Worldwide ethnic distribution of the G protein beta3 subunit 825N allele and its association with obesity in Caucasian, Chinese and Black African individuals. J Am Soc Nephrol 1999;10:1921-30.
11. Rankinen T, Rice T, Leon AS, Skinner JS, Wilmore JH, Rao DC. G protein beta 3 polymorphism and hemodynamic and body composition phenotypes in the HERITAGE Family Study. Physiol Genomics 2002;8:151-7.
12. Stefan N, Stumvoll M, Machicao F, Koch M, Häring HU, Fritsche A. C825T polymorphism of the G protein beta 3 subunit is associated with obesity but not with insulin sensitivity. Obes Res 2004;12:679-83.
13. Grundy SM, Cleeman JI, Daniels SR, Donato KA, Eckel RH, Franklin BA. Diagnosis and management of the metabolic syndrome: an American Heart Association/National Heart, Lung and Blood Institute scientific statement. Curr Opin Cardiol 2006;21:1-6.
14. Lindstrom J, Tuomilehto J. The diabetes risk score: a practical tool to predict type 2 diabetes risk. Diabetes Care 2003;26:725-31.
15. Friedewald WT, Levy RI, Fredrickson DS. Estimation of the concentration of low density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. Clin Chem 1972;18:499-502.
16. Hauner H, Meier M, Wendland G, Kurscheid T, Lauterbach K; Study Group SA. Weight reduction by sibutramine in obesity subjects in primary care medicine: the SAT study. Exp Clin Endocrinol Diabetes 2004;112:201-7.
17. Hsiao DJ, Wu LS, Huang SY, Lin E. Weight loss and body fat reduction under sibutramine therapy in obesity with the C825T polymorphism in the GNB3 gene. Pharmacogenet Genomics 2009;19:730-3.
18. Grudell AB, Sweetser S, Camilleri M, Eckert DJ, Vazquez-Roque MI, Carlson PJ. A controlled pharmaco-genetic trial of sibutramine on weight loss and body composition in obese or overweight adults. Gastroenterology 2008;135:1142-54.
19. Hauner H, Rohrig K, Siffert W. Effects of the G-protein beta3 subunit 825T allele on adipogenesis and lipolysis in cultured human preadipocytes and adipocytes. Horm Metab Res 2002;34:475-80.
20. Ryden M, Faulds G, Hoffstedt J, Wennlund A, Arner P. Effect of the (C825T) Gbeta(3) polymorphism on adrenoceptor-mediated lipolysis in human fat cells. Diabetes 2002;51:1601-8.
21. Su HL, Malbon CC, Wang HY. Increased expression of Gi a2 in mouse embryo stem cells promotes terminal differentiation to adipocytes. Am J Physiol 1993;265:C1729-C35.
22. Moxham CM, Hod Y, Malbon CC. Induction of Gai2-specific antisense RNA in vivo inhibits neonatal growth. Science 1993;260:991-5.
23. Neel JV. Diabetes mellitus: a thrifty genotype rendered detrimental by progress? Am J Hum Genet 1962;14:353-62.
24. Siffert W, Rosskopf D, Siffert G, Busch S, Moritz A, Erbel R. Association of a human G-protein beta3 subunit variant with hypertension. Nat Genet 1998;18:45-8.
25. Snapir A, Heinonen P, Tuomainen TP, Lakka TA, Kauhanen J, Salonen JT. G-protein beta3 subunit C825T polymorphism: no association with risk for hypertension and obesity. J Hypertens 2001;19:2149-55.
26. Michalsen A, Knoblauch NT, Lehmann N, Grossman P, Kerkhoff G, Wilhelm FH. Effect of lifestyle modification on the progression of coronary atherosclerosis, autonomic function and angina - the role of GNB3 C825N polymorphism. Am Heart J 2006;151:870-7.
27. Brand E, Herrmann SM, Nicaud V, Ruidavets JB, Evans A, Arveiler D. The 825C/T polymorphism of the G-protein subunit b3 is not related to hypertension. Hypertension 1999;33:1175-8.
28. Larson N, Hutchinson R, Boerwinkle E. Lack of association of 3 functional gene variants with hypertension in African Americans. Hypertension 2000;35:1297-300.
29. Kato N, Sugiyama T, Morita H, Kuri-hara H, Yamori Y, Yazaki Y. G protein beta3 subunit variant and essential hypertension in Japanese. Hypertension 1998;32:935-8.
30. Niu WQ, Qi Y. Association of a-adducin and G-protein b3 genetic polymorphisms with hypertension: a metaanalysis of Chinese populations. PLoS ONE 2011;6(2):e17052.
31. Khamidullaeva GA, Eliseyeva MR, Nagay AV, Abdullaeva GJ. C825T polymorphism of the G-protein ß3 subunit and its association with essential hypertension in Uzbek males. Turk Kardiyol Dern Ars 2011;39(3):198-204.
32. Klenke S, Kussmann M, Siffert W. The GNB3 C825T polymorphism as a pharmacogenetic marker in the treatment of hypertension, obesity, and depression. Pharmacogenet Genomics 2011;21:594-606.
33. Schunkert H, Hense HW, Döring A, Riegger GA, Siffert W. Association between a polymorphism in the G protein beta3 subunit gene and lower renin and elevated diastolic blood pressure levels. Hypertension 1998;32:510-3.
34. Schelleman H, Stricker BH, Verschuren WM, de Boer A, Kroon AA, de Leeuw PW. Interactions between five candidate genes and antihypertensive drug therapy on blood pressure. Pharmacogenomics J 2006;6:22-6.
35. Turner ST, Schwartz GL, Chapman AB, Boerwinkle E. C825T polymorphism of the G protein beta(3)-subunit and antihypertensive response to a thiazide diuretic. Hypertension 2001;37:739-43.
36. Filigheddu F, Argiolas G, Degortes S, Zaninello R, Frau F, Pitzoi S. Haplotypes of the adrenergic system predict the blood pressure response to beta-blockers in women with essential hypertension. Pharmacogenomics 2010;11:319-25.
37. Filigheddu F, Reid JE, Troffa C, Pinna-Parpaglia P, Argiolas G, Testa A. Genetic polymorphisms of the beta-adrenergic system: association with essential hypertension and response to beta-blockade. Pharmacogenomics J 2004;4:154-60.